CARDIAC DECISION SUPPORT FOR HEALTH PLANS
YOUR INCISION SHOULD BE YOUR DECISION™
A cardiac surgeon and cardiologist independently review one complete record, confer, and co-sign a patient-facing report—giving the member and treating team a clinically grounded second perspective while the plan retains its own coverage responsibilities.
*Clinical-review target begins only after required records and source imaging are received and confirmed complete.
Operative anatomy, strategy, risk, alternatives.
Longitudinal care, medical therapy, catheter options.
The treating team directs care. The health plan retains its coverage and authorization responsibilities.
THE PROGRAM PREMISE
Cardiac decisions sit at the intersection of surgery and cardiology. A useful review must understand both—and leave the member with something precise enough to use with the clinicians who know them.
WHITEGLOVEMD is designed as a focused cardiac pathway: complete record, two independent specialty reads, one conferred report, and an operating model that can be defined with the plan.
WHAT A PLAN CAN ADD
The goal is not another opaque disposition. It is a specialty-specific review pathway with visible inputs, defined handoffs, and an evaluation plan established before results are claimed.
Cardiac surgery and structural-heart cases bring anatomy, procedural strategy, longitudinal cardiology, operative risk, and patient preference into the same decision. The review is designed around that specialty depth.
A cardiac surgeon and cardiologist examine the complete record from different clinical perspectives, confer, and co-sign a single patient-facing report.
The report connects the clinical picture, applicable evidence, risk-model inputs, unresolved questions, and reasonable paths to the records supplied for review.
Eligibility, member entry, service levels, data exchange, reporting, and follow-up measures can be defined for a focused launch. Value is measured from available data rather than assumed in advance.
THE REVIEW MODEL
The service separates record collection from clinical review, gives each specialty an independent read, and preserves a clear boundary between educational decision support, treating-team care, and plan coverage decisions.
The plan, navigation team, care manager, employer channel, or member can initiate access according to the program design. Eligibility and service scope are confirmed before clinical review.
The member can upload what they have and authorize records support. Notes, reports, testing, and source imaging required for the case are identified before the clinical clock starts.
Each physician reads the same complete case through a distinct specialty lens. They can then confer around areas of agreement, uncertainty, and the questions that deserve attention.
The WHITEGLOVE Insights™ report organizes the current plan, guideline context, model-derived risk, reasonable alternatives, missing information, and practical next questions.
When included in the program and supported by permissions and available data, follow-up can document service use, the final care path, member experience, and selected downstream measures.
See the patient-facing deliverable before discussing implementation.
Explore a sample reportCLINICAL INTELLIGENCE WITH LABELS
Each layer is identified for what it is. Model-derived estimates and public program data can inform a decision; neither is presented as a patient-specific guarantee or as a WHITEGLOVEMD company result.
Published model
Published model
Published tool
WHITEGLOVE Composite ScoreProprietary · under evaluationApplicable published models—including STS PROM, EuroSCORE II, and AATS tools—are considered separately. Inputs, applicability, and limitations remain visible rather than being collapsed into false certainty.
When relevant, public reporting can inform discussion of procedure-specific program performance, reported volume, geography, and practical access. Participation, reporting periods, and the limits of program-level data are made clear.
The WHITEGLOVE Composite Score is a proprietary synthesis under evaluation. It is shown separately and is not presented as an independently validated outcome model or as a substitute for physician judgment.
MEASUREMENT FRAMEWORK
Measurement is a program capability and roadmap—not a claim that WHITEGLOVEMD has already produced a particular savings, utilization, or outcome result for health plans.
Eligible cases, referrals, orientations, initiated reviews, completed reviews, and service-level use.
Record-collection time, completeness, clinical turnaround after case completion, report delivery, and consultation participation.
The documented plan at intake, the educational Heart Team review, and the final care path when it is available and appropriate to collect.
Clarity, satisfaction, confidence discussing the decision, and reported ease of navigating the process.
Selected downstream measures only when the required permissions, clinical data, definitions, and follow-up process are in place.
Claims or cost analysis only when actual data, a comparison method, attribution rules, and an agreed time horizon support it.
Interpretation boundary: available measures depend on the program scope, member authorization, data completeness, follow-up design, privacy requirements, minimum-cell rules where relevant, and the agreed analytical method. Association is not automatically causation, and projected economics are not realized results.
POTENTIAL ENTRY MODELS
These are operating-model options for discussion, not claims that a particular integration or deployment is already live.
Members enter through an agreed access path when facing a cardiac surgery or structural-heart decision. Eligibility, funding, outreach, service scope, and reporting are defined with the plan.
A plan or care-management team can explore referral criteria for selected cardiac cases. The independent report can complement an existing workflow without transferring the plan’s coverage responsibilities.
IMPLEMENTATION DISCOVERY
WHITEGLOVEMD does not infer integration, compliance, workflow, or reporting requirements from a template. The plan’s relevant clinical, legal, privacy, security, benefit, operations, and analytics stakeholders define them together.
Request an implementation conversationDefine eligible lines of business, geographies, clinical triggers, and exclusions.
Choose direct access, navigation, care-management referral, employer routing, or a combination.
Define written review, live consultation, records support, and any follow-through included.
Define report recipients, member authorization, treating-team communication, and escalation paths.
Document permitted exchange, minimum necessary data, reporting boundaries, retention, and required reviews.
Set the measures, baseline, follow-up cadence, methodology, and decision rules for expansion.
CLEAR ACCOUNTABILITY
The member’s treating clinicians remain responsible for diagnosis, procedure candidacy, treatment, and follow-up. The plan retains benefit, coverage, authorization, and medical-necessity responsibilities. WHITEGLOVEMD provides independent educational review and the report that supports the next conversation.
Discuss clinical governanceDiagnosis, candidacy, treatment, consent, and follow-up.
Benefits, coverage, authorization, and medical necessity.
Independent record review, Heart Team perspective, and report.
HEALTH-PLAN FAQ
A sound enterprise conversation starts with the operating model: who enters, what is reviewed, what each party receives, what can be measured, and where responsibility remains.
Request a health-plan conversationIt is an independent cardiac decision-support pathway for members facing a cardiac surgery or structural-heart decision. A cardiac surgeon and cardiologist review the complete record independently, confer, and co-sign one patient-facing WHITEGLOVE Insights™ report. Program eligibility, service levels, access, reporting, and funding are defined with the plan.
No. WHITEGLOVEMD provides educational decision support and independent medical-record review. A plan can evaluate where that review belongs in its member, navigation, or case-review workflow, but the plan retains its own coverage, benefit, authorization, and medical-necessity responsibilities.
The model pairs a cardiac surgeon and cardiologist. Each physician reviews the complete case through a distinct specialty lens, then the Heart Team confers and co-signs the patient-facing report. Reviewer assignment, licensure, availability, and any case-specific requirements are addressed within the operating model.
The target begins only after the records and source imaging required for that individual case have been received and confirmed complete. Record collection is a separate phase, and timing can depend on how quickly outside clinicians or facilities release the requested material.
A member can upload available material and authorize records support to help identify and request missing notes, reports, testing, and source imaging. The required record set varies by case. Data exchange, permissions, and any plan or vendor integration are scoped before launch.
That depends on the program design, member authorization, and applicable privacy requirements. The member receives the patient-facing report. Any plan-facing status, reporting, case artifact, or aggregate analysis must be expressly defined, permitted, and limited to the agreed purpose.
Potentially. WHITEGLOVEMD can be evaluated as a focused cardiac pathway, a referral destination, or a complementary decision-support service. Ownership of member outreach, case intake, records, clinical handoff, data exchange, and reporting must be defined with the plan and any existing vendor.
Applicable published risk models are considered separately with their inputs and limitations visible. Public program-level data can add context when relevant, but it is not treated as an individual surgeon outcome or a guarantee. The proprietary WHITEGLOVE Composite Score is labeled separately as a methodology under evaluation, not an independently validated outcome model.
A measurement plan can define access, completion, turnaround, member experience, decision-path information, and selected follow-up outcomes. Claims or savings analysis is only appropriate when the necessary data, baseline, comparison method, attribution rules, and time horizon are agreed. These are measurement capabilities, not current WHITEGLOVEMD outcome or savings claims.
Enterprise pricing is scoped to the eligible population, access model, expected volume, selected service levels, records and implementation work, data exchange, reporting, and evaluation design. WHITEGLOVEMD provides a written commercial scope after the operating model is defined.
Timing depends on scope. A focused referral pathway can require less coordination than a funded benefit or case-triggered program involving eligibility, legal and security review, data exchange, member communications, reporting, or claims analysis. An implementation plan follows discovery and required stakeholder review.
EXPLORE THE FIT
Bring the population, workflow, clinical moment, service goals, data constraints, and questions your organization needs answered. We will map the review pathway before proposing a scope.
Request an enterprise conversation